The supplementation of tocotrienols has shown to significantly reduce glycated haemoglobin (HbA1c) levels in type II diabetic patients, according to a new meta-analysis and systematic review from Malaysia.
Malaysia’s Ministry of Health has approved two health claims for products that contain a specific dosage of palm oil tocotrienol, which is believed will help drive new product development in this area.
The supplementation of astaxanthin and tocotrienol has been shown to improve composite and verbal memory in individuals who have exhibited mild forgetfulness, according to an RCT sponsored by BGG Japan.
Supplementation with delta tocotrienol may improve liver health markers in people with Non-Alcoholic Fatty Liver Disease (NAFLD), says a new study that claims to be the first to the efficacy of this vitamin E form in this population.
Research has shown that the rich tocotrienol content in palm oil could help prevent osteoporosis, with a leading researcher telling us that those who campaign against the industry need to focus on ‘science and evidence’.